PHI Group to Acquire Company with Enhanced Bioavailable

New Post Public Reply Private Reply Replies (0) Message Board
prof
PHI Group to Acquire Company with Enhanced Bioavailable Nutrient and Water Treatment Systems for Premium Organic Farming

http://www.otcmarkets.com/stock/PHIL/news

NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- PHI Group, a U.S. public company focusing on acquisitions and investments in special situations (www.phiglobal.com) (OTCMarkets HIL), has signed a Memorandum of Understanding to acquire 100% of Abound Farms, Inc., a Nevada corporation with hydroponics operations using proprietary enhanced bioavailable nutrient and water treatment systems that can increase crop yields by up to 100 percent compared to prevalent existing methods.

The acquisition is part of the Company’s plan to combine this enhanced bioavailable nutrient and the natural symbiotic immune system developed by Mr. Van Pham, an agricultural expert previously trained under the auspices of the Food and Agriculture Organization (FAO) of the United Nations, for premium organic farming. The combined system is expected to reduce farm water irrigation and costs by as much as 22 percent while eliminating the need for harmful chemical pesticides, synthetic fertilizers and GMO seeds as well as substantially improving soil fertility.

The Company plans to use the combined enhanced bioavailable nutrient and natural symbiotic immune system to grow select medicinal plants for export. It also plans to raise premium organic poultry and other livestock for domestic sale and to develop model-farming programs to grow broader agricultural products without antibiotics and chemicals. This farm model may be replicated and licensed to other farmers in the U.S. and abroad.

The Company has set up a subsidiary “Abundant Farms, Inc.,” a Florida corporation, to acquire a 408-acre farm in Holmes County, Florida, which is a qualified Targeted Employment Area, as defined by the EB-5 Investor Visa Program of the U.S. Citizenship and Immigration Services. The plan is to provide opportunities for international investors to become U.S. permanent residents by investing $500,000 each directly in the company’s farming program. (https://www.uscis.gov/eb-5).

In addition, the Company intends to proceed with the purchase of C&D Fruit and Vegetable Co., a Floridian company that operates a 500-acre farm in Bradenton, Florida, and expects to close this transaction quickly if all the relevant terms and conditions can be met in a timely manner. On another note, PHI Group has recently investigated other special-situations investment opportunities that can potentially generate disruptive growth and help the company leapfrog to a new level in the near future.

Henry Fahman, CEO of PHI Group, said, “We believe by combining the enhanced bioavailable nutrient and natural symbiotic immune systems, we will be able to offer preferred solutions to farming worldwide. While the world is struggling to feed and provide healthcare to 7.2 billion people and while some 475 million acres of farm soil worldwide have lost the mineral nutrients necessary to grow crops, our proprietary technologies can greatly improve the health of crops and livestock that humans consume, thereby dramatically improving human health by reducing illness, cancer and premature death.”

“As global food retail sales surpass $4 trillion annually, we believe our premium organic farming programs have the potential to not only generate significant revenues and profitability but also to revolutionize part of the global farming industry,” Fahman reiterated.

prof
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 3

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Resilience: From Trauma to Shielding Powerhouses

Updated Category News Views 6

A Childhood Steeped in Shadows If you think it's all Wall Street pulse for me, think again. Sometimes you stumble upon stories that hit the gut with more force than any market crash. Enter David Seymour's tale, wrapped up in his newly released autobiography from Palmetto Publishing, bearing the intriguingly gritty title: From paperboy to Secret Service Special Agent. This...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 4

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
Camel Group Expands Battery Portfolio at Canton Fair

Updated Category News Views 3

A Grand Display at the Canton Fair Well, here's one you don't see every day: Camel Group putting on quite the show at the 140th China Import and Export Fair, better known to us as the Canton Fair. Kicked off on October 15, 2026, in Guangzhou, this grand event paraded 'Advanced Manufacturing' as its theme, and Camel's booth was packed to the brim with what might just be...

Continue Reading
ZPMC's Wind Power and Port Projects Earn Top Honors

Updated Category News Views 1

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Continue Reading
Encompass Health Expands With Texas Rehab Hospital

Updated Category News Views 6

A New Chapter in San Antonio's Healthcare Landscape Breaking ground in Texas, Encompass Health has unveiled its latest addition: a 50-bed hospital in San Antonio's Westover Hills. With sheer determination, the largest owner of inpatient rehabilitation hospitals in the U.S. has made its mark, and this isn't just any facility—at over 54,000 square feet, it's a hub for...

Continue Reading
Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

Updated Category News Views 3

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 1

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

Updated Category News Views 6

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Continue Reading
Marengo: Bold Moves in TMB-H Tumor Treatment

Updated Category News Views 0

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...

Continue Reading
iv>